nirmatrelvir/ritonavir
PulseAugur coverage of nirmatrelvir/ritonavir — every cluster mentioning nirmatrelvir/ritonavir across labs, papers, and developer communities, ranked by signal.
-
COVID-19 Surges Amid Shifting Health Guidance and Evolving Vaccines
COVID-19 cases are surging this summer, with new variants like XFG emerging, necessitating updated vaccines. Public health guidance has shifted, with the CDC downgrading its risk maps without clear explanation, raising …
-
COVID-19 cases rise in US; updated vaccine expected this fall
COVID-19 cases are increasing across the United States, though overall respiratory illness remains low due to widespread immunity. An updated vaccine targeting the JN.1-lineage XFG variant is expected in early fall and …
-
Pfizer CEO bets $23B on oncology, leveraging AI for cancer breakthroughs
Pfizer CEO Albert Bourla is spearheading a significant strategic shift for the company, reallocating $23 billion from its COVID-19 windfalls towards oncology research and development. This pivot aims to secure Pfizer's …
-
Pfizer CEO admits using 'emotional blackmail' to drive COVID-19 vaccine production
Pfizer CEO Albert Bourla has revealed his use of intense motivational tactics, which he described as "emotional blackmail," to drive his teams to achieve unprecedented goals during the COVID-19 pandemic. Bourla employed…